1. Home
  2. KLXE vs NSRX Comparison

KLXE vs NSRX Comparison

Compare KLXE & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

N/A

Current Price

$2.81

Market Cap

44.8M

Sector

Energy

ML Signal

N/A

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.39

Market Cap

53.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KLXE
NSRX
Founded
2018
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.8M
53.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
KLXE
NSRX
Price
$2.81
$2.39
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$20.50
AVG Volume (30 Days)
291.4K
142.6K
Earning Date
03-11-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$636,600,000.00
N/A
Revenue This Year
$3.89
N/A
Revenue Next Year
$4.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$2.40
52 Week High
$3.74
$9.99

Technical Indicators

Market Signals
Indicator
KLXE
NSRX
Relative Strength Index (RSI) 55.13 26.59
Support Level $1.59 N/A
Resistance Level $3.09 $5.20
Average True Range (ATR) 0.29 0.36
MACD -0.00 -0.16
Stochastic Oscillator 58.00 7.03

Price Performance

Historical Comparison
KLXE
NSRX

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: